A common GRN polymorphism associated with risk for AD and FTD modestly reduces progranulin levels (Nicholson et al. 2014; Rademakers et al. 2008), indicating that even mild reduction of progranulin may increase risk for neurodegenerative disease. This evidence concerns the gene GRN and neurodegenerative disease.